Market

ACCRETION PHARMACEUTICALS LTD.

  • NSE CodeACCPLST
  • BSE Code-
  • ISININE0T8T01010
  • IndustryPharmaceuticals


Company Information

Management

Ms. Bhavika Dhaval Makadia

Co. Secretary & Compl. Officer

Mr. Harshad Nanubhai Rathod

Chief Financial Officer

Incorporation Year

18/12/2012

Registered Address

Registered Office : 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Sanand,
Ahmedabad, Gujarat - 382213
Tel: 079-9714882929

Registrar Office

KFin Technologies Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Corporate News

Accretion Pharma. - Investor Presentation

15-May-2026|2:49PM

Accretion Pharmaceuticals Limited has informed the Exchange about Investor

Accretion Pharma. - Press Release

15-May-2026|2:05PM

Accretion Pharmaceuticals Limited has informed the Exchange regarding a pre

Accretion Pharma. - Change in Auditors

08-May-2026|4:34PM

Accretion Pharmaceuticals Limited has informed the Exchange regarding Chang

Accretion Pharma. - Appointment

08-May-2026|4:22PM

Accretion Pharmaceuticals Limited has informed the Exchange regarding Appoi

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug77.99221.14
Aarti Drug380.403,471.91
Aarti Pharma633.255,740.90
Abbott India26,855.0057,065.00
Accent Micro441.951,060.19

MF Holding

No Data Available

Board Meetings

DatePurpose
08/05/2026Audited Results & O..
14/11/2025Quarterly Results
10/06/2025Audited Results & O..
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.